cobas® EBV

Quantitative nucleic acid test for use on the cobas® 5800/6800/8800 systems
IVD For in vitro diagnostic use.

Setting a new standard for transplant patients

The cobas® EBV test provides reliable, standardized, high-quality results for the improved management of transplant patients at risk of infection. The test is intended as an aid in the diagnosis and management of Epstein-Barr Virus (EBV) in transplant patients, with results used to guide treatment decisions.2 The test is for use on the automated cobas® 5800/6800/8800 systems.

Epstein-Barr virus

Epstein-Barr Virus (EBV) diseases, including EBV-associated post-transplant lymphoproliferative disorder (PTLD), remain important causes of morbidity and mortality in patients undergoing solid organ transplantation and hematopoietic cell transplantation.1 Early detection with best-in-class monitoring tools provides actionable results, which enable informed treatment decisions.

Benefits at a glance<sup>2</sup>

Benefits at a glance2

Acronym ‘WHO’ combined with a tick, illustrating that cobas EBV results are traceable to WHO international standards

Results traceable to the WHO International Standard and reporting in IU/mL for improved harmonization in testing results across hospitals and institutions.

Target with tick icon, illustrating the reliable and reproducible results of the cobas EBV assay

A dual target assay design to provide reliable and reproducible results for reassurance in clinical decision making.

Twisting arrow icon, illustrating the flexibility of EBV testing on the cobas 5800/6800/8800 Systems

Ability to perform critical transplant testing (CMV, EBV, BKV) from a single sample on the cobas 5800/6800/8800 systems with an industry-leading menu, absolute automation, and proven performance.

cobas EBV test for cobas 5800/6800/8800 systems performance2

View full table

cobas EBV test for cobas 5800/6800/8800 systems performance2

Product specification 

Value

Sample type 

EDTA plasma

Minimum amount of sample required 

350 µL

Sample processing volume 

200 µL

Analytical sensitivity 

18.8 IU/mL

Linear range 

35.0 IU/mL to 1E+08 IU/mL

Genotypes detected 

Genotypes 1 and 2

Overall precision 

SD 0.02 - 0.17 log10

Use left and right arrow keys to scroll between the tabs

Overview

Ordering information

error errorMessage
Sorry, we couldn't find the content you are looking for
Please try again later

Compatible products

No products found for this filter.

Related products

Contact us

Do you have questions about our products or services? We’re here to help. Contact a Roche representative in your region.

References

  1. Allen UD, Preiksaitis JK, AST Infectious Diseases Community of Practice. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13652.
  2. F. Hoffmann-La Roche Ltd. cobas® EBV quantitative nucleic acid test for use on cobas® 5800/6800/8800 systems. Package insert (09478116001-04EN). (v4.0). 2024.